002940 昂利康
已收盘 04-30 15:00:00
资讯
新帖
简况
昂利康2023年研发费用增长53% 2024年一季度继续高增136%
上海 · 04-29
昂利康2023年研发费用增长53% 2024年一季度继续高增136%
图解昂利康一季报:第一季度单季净利润同比减40.05%
证券之星 · 04-27
图解昂利康一季报:第一季度单季净利润同比减40.05%
昂利康最新公告:一季度净利润2821.87万元 同比下降40.05%
证券之星 · 04-26
昂利康最新公告:一季度净利润2821.87万元 同比下降40.05%
昂利康(002940.SZ)发一季度业绩,净利润2821.87万元,同比减少40.05%
智通财经 · 04-26
昂利康(002940.SZ)发一季度业绩,净利润2821.87万元,同比减少40.05%
昂利康(002940.SZ)与亲合力签署战略合作协议之研发合作及授权许可协议
智通财经网 · 02-04
昂利康(002940.SZ)与亲合力签署战略合作协议之研发合作及授权许可协议
加载更多
公司概况
公司名称:
浙江昂利康制药股份有限公司
所属行业:
医药制造业
上市日期:
2018-10-23
主营业务:
浙江昂利康制药股份有限公司主要从事医药生产制造业务,主要包括化学原料药、化学制剂和药用辅料的研发、生产和销售。主要产品包括口服头孢类抗生素原料药(包括头孢氨苄、头孢拉定和头孢克洛)和alpha酮酸原料药等原料药品种、抗感染类制剂(包括头孢克肟胶囊、头孢克洛缓释片和头孢克洛颗粒等)、心血管类制剂(包括苯磺酸左氨氯地平片、硝苯地平缓释片等)、明胶空心胶囊。公司为高新技术企业,公司研发中心被浙江省科学技术厅认定为省级高新技术企业研究开发中心、省重点企业研究院,并设有院士专家工作站和外国专家工作站。
发行价格:
23.07
{"stockData":{"symbol":"002940","market":"SZ","secType":"STK","nameCN":"昂利康","latestPrice":17.02,"timestamp":1714460592000,"preClose":16.58,"halted":0,"volume":4647721,"delay":0,"floatShares":185000000,"shares":202000000,"eps":0.5925,"marketStatus":"已收盘","marketStatusCode":5,"change":0.44,"latestTime":"04-30 15:00:00","open":16.36,"high":17.96,"low":16.3,"amount":79443400,"amplitude":0.1001,"askPrice":17.03,"askSize":22,"bidPrice":17.02,"bidSize":16,"shortable":0,"etf":0,"ttmEps":0.5925,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":16.58,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":18.24,"lowLimit":14.92,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":201728186,"pbRate":2.09,"roa":"--","roe":"1.77%","epsLYR":0.69,"committee":0.158824,"marketValue":3433000000,"floatMarketCap":3153000000,"peRate":28.72574,"changeRate":0.0265,"turnoverRate":0.0251,"status":0},"requestUrl":"/m/hq/s/002940/","defaultTab":"news","newsList":[{"id":"2431200240","title":"昂利康2023年研发费用增长53% 2024年一季度继续高增136%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431200240","media":"上海","top":-1,"share":"https://www.laohu8.com/m/news/2431200240?lang=zh_cn&edition=full","pubTime":"2024-04-29 11:38","pubTimestamp":1714361880,"startTime":"0","endTime":"0","summary":"值得注意的是,在2023年研发投入同比增长53.05%的基础上,2024年一季度,昂利康研发投入继续高增,当期研发费用为4908.60万元,占公司当期营收的12%,较上年同期的2076.05万元增加2832.55万元,同比增长136.44%。据了解,昂利康增加的研发费用主要用于重要特色的仿制药、重要改良型新药、创新药以及兽药(宠物药)等领域的研发。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-29/doc-inatninf1501924.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-04-29/doc-inatninf1501924.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430778252","title":"图解昂利康一季报:第一季度单季净利润同比减40.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430778252","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430778252?lang=zh_cn&edition=full","pubTime":"2024-04-27 02:27","pubTimestamp":1714156034,"startTime":"0","endTime":"0","summary":"证券之星消息,昂利康2024年一季报显示,公司主营收入4.08亿元,同比下降3.89%;归母净利润2821.87万元,同比下降40.05%;扣非净利润2158.87万元,同比下降32.33%;负债率40.37%,投资收益-220.61万元,财务费用-379.4万元,毛利率39.74%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042700004234.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430273881","title":"昂利康最新公告:一季度净利润2821.87万元 同比下降40.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430273881","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430273881?lang=zh_cn&edition=full","pubTime":"2024-04-26 19:39","pubTimestamp":1714131585,"startTime":"0","endTime":"0","summary":"昂利康公布2024年第一季度报告,报告期营业收入4.08亿元,同比下降3.89%;归属于上市公司股东的净利润2821.87万元,同比下降40.05%;归属于上市公司股东的扣除非经常性损益的净利润2158.87万元,同比下降32.33%;基本每股收益0.14元。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600049161.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430222575","title":"昂利康(002940.SZ)发一季度业绩,净利润2821.87万元,同比减少40.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430222575","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430222575?lang=zh_cn&edition=full","pubTime":"2024-04-26 18:58","pubTimestamp":1714129105,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昂利康(002940.SZ)发布2024年第一季度报告,营业收入4.08亿元,同比减少3.89%。归属于上市公司股东的净利润2821.87万元,同比减少40.05%。归属于上市公司股东的扣除非经常性损益的净利润2158.87万元,同比减少32.33%。基本每股收益0.14元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111971.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2408131904","title":"昂利康(002940.SZ)与亲合力签署战略合作协议之研发合作及授权许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2408131904","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2408131904?lang=zh_cn&edition=full","pubTime":"2024-02-04 17:03","pubTimestamp":1707037380,"startTime":"0","endTime":"0","summary":"昂利康发布公告,2024年2月2日,公司与上海亲合力生物医药科技股份有限公司签署了《战略合作协议之研发合作及授权许可协议》,双方基于亲合力的肿瘤微环境特异激活平台技术进行合作开发,同时,亲合力就其QHL-1618药物分子向昂利康授予许可,昂利康获得亲合力一项排他的、需支付许可费的、不可转让的、可多级分许可的专利许可,昂利康在许可区域范围内拥有基于QHL-1618药物分子的药品的研发、生产、商业化独家权益。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-04/doc-inafwinh1739065.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-02-04/doc-inafwinh1739065.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2018-10-23","address":"浙江省绍兴市嵊州市嵊州大道北1000号","stockEarnings":[{"period":"1week","weight":0.1131},{"period":"1month","weight":0.0745},{"period":"3month","weight":0.0841},{"period":"6month","weight":-0.1511},{"period":"1year","weight":-0.1539},{"period":"ytd","weight":-0.216}],"companyName":"浙江昂利康制药股份有限公司","boardCode":"AI0027","perCapita":"19855股","boardName":"医药制造业","registeredCapital":"20172万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":" 浙江昂利康制药股份有限公司主要从事医药生产制造业务,主要包括化学原料药、化学制剂和药用辅料的研发、生产和销售。主要产品包括口服头孢类抗生素原料药(包括头孢氨苄、头孢拉定和头孢克洛)和alpha酮酸原料药等原料药品种、抗感染类制剂(包括头孢克肟胶囊、头孢克洛缓释片和头孢克洛颗粒等)、心血管类制剂(包括苯磺酸左氨氯地平片、硝苯地平缓释片等)、明胶空心胶囊。公司为高新技术企业,公司研发中心被浙江省科学技术厅认定为省级高新技术企业研究开发中心、省重点企业研究院,并设有院士专家工作站和外国专家工作站。","serverTime":1714708720577,"listedPrice":23.07,"stockholders":"9331人(较上一季度增加0.97%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昂利康(002940)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昂利康,002940,昂利康股票,昂利康股票老虎,昂利康股票老虎国际,昂利康行情,昂利康股票行情,昂利康股价,昂利康股市,昂利康股票价格,昂利康股票交易,昂利康股票购买,昂利康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昂利康(002940)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昂利康(002940)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}